Literature DB >> 29127033

The role of TGFβ receptor 1-smad3 signaling in regulating the osteoclastic mode affected by fluoride.

Haolan Yu1, Ningning Jiang1, XiuHua Yu2, Zhitao Zhao1, Xiuyun Zhang1, Hui Xu3.   

Abstract

Studies that have focused on the role TGFβ signaling plays in osteoclast activity are gradually increasing; however, literature is rare in terms of fluorosis. The aim of this study is to observe the role the TβR1/Smad3 pathway plays in fluoride regulating cellsosteoclast-like cells that are under the treatment of TGFβ receptor 1 kinase. The RANKL-mediated osteoclast-like cells from RAW264.7 cells were used as osteoclast precursor model. The profile of miRNA expression in fluoride-treated osteoclast-like cells exhibited 303 upregulated miRNAs, 61 downregulated miRNAs, and further drew 37 signaling pathway maps by KEGG and Biocarta pathway enrichment analysis. TGFβ and its downstream effectors were included among them. Osteoclast viability, formation and function were detected via MTT method, bone resorption pit and tartrate-resistant acid phosphatase (TRACP) staining, respectively. Results demonstrated that different doses of fluoride exhibited a biphasic effect on osteoclast cell viability, differentiation, formation and function. It indicated that a low dose of fluoride treatment stimulated them, but high dose inhibited them. SB431542 acted as TβR1 kinase inhibitor and blocked viability, formation and function of osteoclast-like cells regulated by fluoride. The expression of the osteoclast marker, RANK, and TβR1/Smad3 at gene and protein level was analyzed under fluoride with and without SB431542 treatment. Fluoride treatment indicated little effect on the RANK protein expression; however it significantly influenced TRACP expression in osteoclast-like cells. The stimulation of fluoride on the expression of Smad3 gene and phosphorylated Smad3 protein exhibited dose-dependent manner. SB431542 significantly impeded phosphorylation of Smad3 protein and TRACP expression in osteoclast-like cells that were exposed to fluoride. Our work demonstrated that TGFβ signaling played a key role in fluoride regulating osteoclast differentiation, formation and function. It elucidated that TβR1/Smad3 pathway participated in the mechanism of biphasic modulation of osteoclast mode regulated by fluoride.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Fluoride; Osteoclast; RAW264.7 cells; Smad3; Transforming growth factor beta; Transforming growth factor beta receptor1

Mesh:

Substances:

Year:  2017        PMID: 29127033     DOI: 10.1016/j.tox.2017.11.009

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  5 in total

1.  Fluoride Exposure Provokes Mitochondria-Mediated Apoptosis and Increases Mitophagy in Osteocytes via Increasing ROS Production.

Authors:  Yun Zhang; Fanhe Dong; Zihan Wang; Bingbing Xu; Tao Zhang; Qiqi Wang; Qiao Lin
Journal:  Biol Trace Elem Res       Date:  2022-10-18       Impact factor: 4.081

2.  Role of TGF-β1 in Fluoride-Treated Osteoblasts at Different Stages.

Authors:  Ningning Jiang; Wenshu Xu; Zhongyuan Zhang; Hui Jin; Yang Yang; Jingmin Zhang; Hui Xu
Journal:  Biol Trace Elem Res       Date:  2021-05-24       Impact factor: 3.738

3.  miR-378d is Involved in the Regulation of Apoptosis and Autophagy of and E2 Secretion from Cultured Ovarian Granular Cells Treated by Sodium Fluoride.

Authors:  Qun Chen; Zhen Li; Zhao Xu; Chen Chen; Jiawei Wang; Jinyuan Zhu; Zhaoheng Dong
Journal:  Biol Trace Elem Res       Date:  2021-01-06       Impact factor: 3.738

Review 4.  The pathogenesis of endemic fluorosis: Research progress in the last 5 years.

Authors:  Wei Wei; Shujuan Pang; Dianjun Sun
Journal:  J Cell Mol Med       Date:  2019-02-19       Impact factor: 5.310

5.  Fluorine-contained hydroxyapatite suppresses bone resorption through inhibiting osteoclasts differentiation and function in vitro and in vivo.

Authors:  Shibo Liu; Hao Zhou; Hanghang Liu; Huanzhong Ji; Wei Fei; En Luo
Journal:  Cell Prolif       Date:  2019-04-10       Impact factor: 6.831

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.